Aptevo Therapeutics and the ADAPTIR™ (Modular Protein Technology) Platform: The Future of Immuno-oncology
Aptevo Therapeutics is a biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Our core technology is the ADAPTIR™ (modular protein technology) platform. We also have four commercial products that generate revenue in the areas of hematology and infectious diseases, as well as various investigational stage product candidates in immuno-oncology.
Nov 27 - Nov 29, 201830th Annual Piper Jaffray Healthcare Conference
Nov 9, 2018Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting
Oct 2, 2018
9:00 AM EDTLadenburg Thalmann 2018 Healthcare Conference